Mainz Biomed N.V (MYNZ) Gross Margin: 2021-2025
Historic Gross Margin for Mainz Biomed N.V (MYNZ) over the last 2 years, with Jun 2025 value amounting to 100.00%.
- Mainz Biomed N.V's Gross Margin changed negligibly% to 100.00% in Q2 2025 from the same period last year, while for Jun 2025 it was 99.74%, marking a year-over-year increase of 276.00%. This contributed to the annual value of 64.31% for FY2024, which is 739.00% up from last year.
- Per Mainz Biomed N.V's latest filing, its Gross Margin stood at 100.00% for Q2 2025, which was down 0.00% from 100.00% recorded in Q4 2024.
- In the past 5 years, Mainz Biomed N.V's Gross Margin registered a high of 100.00% during Q4 2021, and its lowest value of 18.78% during Q4 2022.
- Over the past 3 years, Mainz Biomed N.V's median Gross Margin value was 62.74% (recorded in 2023), while the average stood at 75.15%.
- In the last 5 years, Mainz Biomed N.V's Gross Margin crashed by 8,122bps in 2022 and then skyrocketed by 4,396bps in 2023.
- Quarterly analysis of 5 years shows Mainz Biomed N.V's Gross Margin stood at 100.00% in 2021, then crashed by 8,122bps to 18.78% in 2022, then surged by 4,396bps to 62.74% in 2023, then soared by 3,726bps to 100.00% in 2024, then remained steady at 100.00% in 2025.
- Its Gross Margin was 100.00% in Q2 2025, compared to 100.00% in Q4 2024 and 100.00% in Q2 2024.